M.D. Sass LLC Grows Holdings in Danaher Corporation (NYSE:DHR)

M.D. Sass LLC boosted its stake in Danaher Corporation (NYSE:DHR) by 100.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 313,321 shares of the conglomerate’s stock after acquiring an additional 157,334 shares during the period. Danaher accounts for approximately 5.7% of M.D. Sass LLC’s holdings, making the stock its 5th biggest holding. M.D. Sass LLC’s holdings in Danaher were worth $64,231,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at $27,000. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares in the last quarter. Hurley Capital LLC bought a new stake in shares of Danaher during the 4th quarter valued at $34,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher during the 1st quarter valued at $31,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on DHR. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Wolfe Research lowered their price target on Danaher from $275.00 to $220.00 and set an “outperform” rating for the company in a research report on Monday, April 7th. JPMorgan Chase & Co. lowered their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Deutsche Bank Aktiengesellschaft lowered their price target on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Argus lowered their price target on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $247.61.

Danaher Trading Down 0.0%

Danaher stock opened at $197.08 on Friday. The business has a 50-day simple moving average of $197.49 and a two-hundred day simple moving average of $202.44. The company has a market cap of $141.12 billion, a P/E ratio of 41.93, a P/E/G ratio of 2.74 and a beta of 0.73. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.72 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Friday, June 27th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Insider Activity

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.